Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
18:11:14 EST Sun 07 Dec 2025
Enter Symbol
or Name
USA
CA



Forgot password?
Trouble logging in?
Login ID:
Password:
Save

News last 24 hour(s) - 27 items News ReleasesIn The NewsOther CAUS
DateSymPriceTypeHeadline
2025-12-07 18:02U:MATWNews ReleaseMatthews International Provides Update on Actions to Create Shareholder Value and Addresses Director Nominations
2025-12-07 18:00U:SLSNews ReleaseSELLAS Life Sciences Presents Positive Phase 2 Data of SLS009 in Combination with AZA/VEN in Relapsed/Refractory AML-MR at ASH 2025
2025-12-07 18:00U:ONCNews ReleaseSonrotoclax Data at ASH 2025 Confirm Foundational Potential Across B-cell Malignancies
2025-12-07 17:07U:CYGGFNews ReleaseDrilling hits wide zone of mineralisation in new area well outside resource
2025-12-07 17:00U:ITNews ReleaseGartner Announces Gartner Finance Symposium/Xpo 2026 in Sydney
2025-12-07 16:30U:REGNNews ReleaseLynozyfic(TM) (linvoseltamab) Monotherapy in Newly Diagnosed Multiple Myeloma (NDMM) Shows Impressive Responses, Supporting Rationale as a Potential Foundation in Frontline Treatment
2025-12-07 16:30U:LYELNews ReleaseLyell Immunopharma Presents New Clinical Data from Ongoing Trial of Ronde-Cel Showing High Rates of Durable Complete Responses in Patients with Large B-cell Lymphoma at the 67th ASH Annual Meeting and Exposition
2025-12-07 16:30U:LLYNews ReleaseLilly's Jaypirca (pirtobrutinib) met its primary endpoint in first-of-its-kind, head-to-head Phase 3 study versus Imbruvica (ibrutinib)
2025-12-07 16:00U:WVENews ReleaseWave Life Sciences to Announce Interim Data from the Phase 1 INLIGHT Trial of WVE-007 (INHBE) for Obesity on Monday, December 8, 2025
2025-12-07 14:00U:PLDNews ReleasePrologis announces redemption of 3.00% Notes due 2026
2025-12-07 12:01U:CSLLYNews ReleaseData Published in the New England Journal of Medicine Confirm the Long-term Durability and Safety of HEMGENIX(TM) (etranacogene dezaparvovec-drlb) Over Five Years
2025-12-07 12:00U:IAALFNews ReleaseIBC Advanced Alloys Reports Results from its 2025 Annual General Meeting
2025-12-07 11:00U:DYNNews ReleaseDyne Therapeutics to Host Investor Conference Call and Webcast to Review Topline Results from Registrational Expansion Cohort (REC) of DELIVER Clinical Trial of Z-Rostudirsen (DYNE-251) in Duchenne Muscular Dystrophy; Tomorrow, December 8 at 8:00 a.m. ET
2025-12-07 09:30U:RIGLNews ReleaseRigel Presents Updated Data from the Ongoing Phase 1b Study Evaluating R289 in Patients with Lower-Risk MDS at the 67th ASH Annual Meeting and Exposition
2025-12-07 09:30U:NYAXNews ReleaseNayax Considering an Offering of Notes and Warrants in Israel
2025-12-07 09:30U:INCYNews ReleaseIncyte Announces New Positive Data for INCA033989, its First-In-Class mutCALR-Targeted Monoclonal Antibody, in Patients with Myelofibrosis Presented at ASH 2025
2025-12-07 09:30U:INCYNews ReleaseIncyte's First-in-Class mutCALR-Targeted Monoclonal Antibody, INCA033989, Granted Breakthrough Therapy Designation by U.S. FDA
2025-12-07 08:05U:PRMENews ReleasePrime Medicine Announces The New England Journal of Medicine Publication of PM359 Clinical Data for the Treatment of Chronic Granulomatous Disease
2025-12-07 08:00U:GILDNews ReleaseYescarta(TM) Delivers Consistent Safety, Efficacy, and Quality of Life Benefits Across Broad Range of Relapsed/Refractory Large B-cell Lymphoma Patients in New Analysis at ASH 2025
2025-12-07 08:00U:ALXONews ReleaseALX Oncology Announces Positive Results from Ongoing Investigator-Sponsored Phase 2 Trial Evaluating Evorpacept in Combination with Standard-of-Care Treatment in Patients with Indolent B-cell Non-Hodgkin Lymphoma, at ASH Annual Meeting
2025-12-07 07:50U:GMABNews ReleaseGenmab Presents Pivotal Phase 3 Data from EPCORE(TM) FL-1 Trial Demonstrating Clinical Benefit of EPKINLY(TM) (epcoritamab-bysp) in Combination with Rituximab and Lenalidomide (R2) in Patients with Relapsed or Refractory Follicular Lymphoma
2025-12-07 07:00U:MOLNNews ReleaseMolecular Partners Presents Updated Data from Ongoing Phase 1/2a Trial of MP0533 in AML at ASH Annual Meeting
2025-12-07 03:00U:ONNVFNews ReleaseOnco-Innovations Engages Investment Bank to Pursue Nasdaq Cross-listing and Potential Concurrent Equity Offering
2025-12-07 01:25U:EMSKFNews ReleaseGermanium Mining Corp. Enhances Visibility of Germanium Project Portfolio Through Awareness Initiatives
2025-12-07 00:11U:ZLABNews ReleaseZai Lab Announces Updates to China's National Reimbursement Drug List
2025-12-06 22:40U:NUVBNews ReleaseInnovent Announces Inclusion of Seven Innovative Drugs including TYVYT New Indication and SYCUME in China's National Reimbursement Drug List
2025-12-06 20:45U:ABTNews ReleaseUniversity of Wisconsin Wins Abbott and Big Ten's 'We Give Blood' Competition as Campaign Donations Surge 319%, Helping Save Nearly 250,000 Lives